Targeted screening covering CS core genes (FGFR2, FGFR3, TWIST1, FGFR1, EFNB1, TCF12, ERF) has a high diagnostic yield of up to 90% in SCS patients with the most recognizable classical phenotypes. This evidence concerns the gene FGFR1 and Saethre-Chotzen syndrome.